Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2026-01-17 @ 10:33 AM
Study NCT ID:
NCT04075292
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-21
First Post:
2019-08-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-19
First Submit QC Date:
None
Study First Post Date:
2019-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-23
Results First Submit QC Date:
None
Results First Post Date:
2025-01-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED